Increased Monocyte Inflammatory Responses to Oxidized LDL Are Associated with Insulin Resistance in HIV-Infected Individuals on Suppressive Antiretroviral Therapy
VIRUSES-BASEL
Authors: Mitchell, Brooks I.; Laws, Elizabeth I.; Chow, Dominic C.; Sah Bandar, Ivo N.; Gangcuangco, Louie Mar A.; Shikuma, Cecilia M.; Ndhlovu, Lishomwa C.
Abstract
Despite long term antiretroviral therapy (ART), insulin resistance (IR) is common among people living with HIV/AIDS (PLWHA) exposing this population to a greater risk of cardiometabolic complications when compared to their uninfected counterparts. We previously identified an expansion in monocyte subpopulations in blood that were linked to the degree of IR in persons with HIV on stable ART. In this study, we directly assessed monocyte inflammatory functional properties from PLWHA on ART (n = 33) and HIV-uninfected controls (n = 14) of similar age, gender, and cardiovascular disease risk and determined the relationship with IR (homeostatic model assessment-insulin resistance (HOMA-IR)), calculated from fasting blood glucose and insulin measurements. Peripheral blood mononuclear cells were stimulated with oxidized low-density lipoproteins (oxLDL) and polyfunctional monocyte cytokine responses (IL-1 beta, IL-6, IL-8, or TNF-alpha) were determined by flow cytometry. Higher monocyte IL-1 beta and IL-8 responses to oxLDL were associated with higher IR in PLWHA but not in the control group. We observed that higher basal monocyte cytokine responses were associated with both duration since HIV diagnosis and ART initiation. In the management of IR in chronic HIV, strategies lowering monocyte IL-1 beta and IL-8 responses should be considered in addition to ART in order to limit adverse cardio-metabolic outcomes.
Few amino acid signatures distinguish HIV-1 subtype B pandemic and non-pandemic strains
PLOS ONE
Authors: Arantes, Ighor; Ribeiro-Alves, Marcelo; S. D. de Azevedo, Suwellen; Delatorre, Edson; Bello, Gonzalo
Abstract
The Human Immunodeficiency Virus Type I (HIV-1) subtype B comprises approximately 10% of all HIV infections in the world. The HIV-1 subtype B epidemic comprehends a pandemic variant (named B-PANDEMIC) disseminated worldwide and non-pandemic variants (named B-CAR) that are mostly restricted to the Caribbean. The goal of this work was the identification of amino acid signatures (AAs) characteristic to the B(CAR)and B(PANDEMIC)variants. To this end, we analyzed HIV-1 subtype B full-length (n = 486) and partial (n = 814) genomic sequences from the Americas classified within the B(CAR)and B(PANDEMIC)clades and reconstructed the sequences of their most recent common ancestors (MRCA). Analysis of contemporary HIV-1 sequences revealed 13 AAs between B(CAR)and B(PANDEMIC)variants (four on Gag, three on Pol, three on Rev, and one in Vif, Vpu, and Tat) of which only two (one on Gag and one on Pol) were traced to the MRCA. All AAs correspond to polymorphic sites located outside essential functional proteins domains, except the AAs in Tat. The absence of stringent AAs inherited from their ancestors between modern B(CAR)and B(PANDEMIC)variants support that ecological factors, rather than viral determinants, were the main driving force behind the successful spread of the B(PANDEMIC)strain.